Altaire Recalls Grandall Oftal-Mycin Ophthalmic Ointment Due to Sterility Concerns
Altaire Pharmaceuticals is recalling Grandall Oftal-Mycin Ophthalmic Ointment because the product lacks assurance of sterility. The recall covers specific lots distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving sterility issues in ophthalmic products which pose a risk of infection.
Plain-English summary
Altaire Pharmaceuticals, Inc. is recalling Grandall Oftal-Mycin Ophthalmic Ointment, 3.5 g, due to a lack of assurance of sterility. The affected product is distributed nationwide in the United States.
The recall includes the following lot numbers and expiration dates: QJD (Exp 10/19), RFK (Exp 6/20), SCB (Exp 3/21), and TBI (Exp 2/22). The FDA has classified this recall as Class II, indicating that use of the product could cause temporary or medically reversible health consequences.
Consumers should stop using the recalled ointment and contact their healthcare provider or pharmacist for guidance on next steps. The source text does not report any specific illnesses or injuries associated with this recall.
The recalled product
- Product
- Grandall Oftal-Mycin Ophthalmic Ointment, Product Size: 3.5 g
- Manufacturer
- Altaire Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic Ointment
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: QJD
- Exp 10/19
- RFK
- Exp 6/20
- SCB
- Exp 3/21
- TBI
- Exp 2/22
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 134 recalled by Altaire Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 134 products in this recall →Related recalls
Same manufacturer · Altaire Pharmaceuticals, Inc.
See all →- SevereCVS Health Dry Eye Relief Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereCVS Health Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls Equate Support Advanced Twin Pack Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
- SevereAltaire Recalls OCuSOFT Ophthalmic Ointment Due to Sterility Concerns
FDA (Drugs) · 2019-11-27
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15